| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $18,053,676 ) (Continued on the next page) |
| | 2025 | 2025 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01MD018174 | Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations | 001 | 3 | NIH | 4/24/2025 | $69,777 |
| | 2025 | 2025 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | U01DA053672 | Genetics of oxycodone intake in a hybrid rat diversity panel. | 000 | 5 | NIH | 2/27/2025 | $604,731 |
| | 2025 | 2025 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01EY033005 | Predicting the risk of glaucoma from structural, functional, and genetic factors using artificial intelligence | 000 | 4 | NIH | 3/19/2025 | $440,335 |
| | 2025 | 2025 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | U01AI172991 | Mitigation of GI-ARS by Lactobacillus species | 000 | 3 | NIH | 11/25/2024 | $473,168 |
| | 2025 | 2025 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01AG075813 | The interaction effects of genetic variants, age, diet, sex and mitochondrial copy number on Alzheimer's disease, aging-phenotypes and longevity | 000 | 4 | NIH | 11/14/2024 | $635,624 |
| | 2025 | 2025 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | F30CA271570 | Identifying a transcriptional core regulatory circuitry and other critical transcription factor dependencies in H3.3 G34R/V high-grade glioma | 000 | 4 | NIH | 5/5/2025 | $53,714 |
| | 2025 | 2025 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01DA056523 | Identification of gene variants mediating the behavioral and physiological response to THC | 000 | 3 | NIH | 4/22/2025 | $735,832 |
| | 2025 | 2025 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01CA267643 | Managing Obesity by Leveraging Health Information Technology to Lower Cancer Risk | 000 | 4 | NIH | 12/23/2024 | $575,159 |
| | 2025 | 2025 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01AA029673 | Fetal cerebral arteries and prenatal alcohol exposure | 000 | 4 | NIH | 1/20/2025 | $570,069 |
| | 2025 | 2025 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01DK134937 | Prenatal Longitudinal Metabolomics Profiling for Early Childhood Growth Trajectories and Obesity Risk in a US Biracial Birth Cohort | 000 | 3 | NIH | 4/30/2025 | $749,261 |
| | 2025 | 2025 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01NS131106 | Discovery of Novel Selective Androgen Receptor Degraders (SARDs) for the Treatment of Spinobulbar Muscular Atrophy (SBMA) or Kennedy’s Disease | 000 | 2 | NIH | 11/15/2024 | $337,272 |
| | 2025 | 2025 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R21NS136070 | Inhibiting mPGES-1 as a countermeasure to mitigate organophosphate-induced neurotoxicity | 000 | 2 | NIH | 5/2/2025 | $231,000 |
| | 2025 | 2025 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01CA262112 | Determining susceptibility loci in triple negative breast cancer using a novel pre-clinical model | 000 | 4 | NIH | 1/17/2025 | $367,486 |
| | 2025 | 2025 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01AA029270 | Defining the Role of Intestinal Calcium Channels in Alcoholic Liver Damage. | 000 | 4 | NIH | 5/2/2025 | $497,731 |
| | 2025 | 2025 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | K23HL157554 | Genetic modifiers of Sickle Cell Kidney Disease | 000 | 4 | NIH | 3/3/2025 | $168,179 |
| | 2025 | 2025 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01AI140405 | Adipose T cell microRNAs (miRs) regulate macrophage function during obesity | 000 | 6 | NIH | 2/13/2025 | $363,517 |
| | 2025 | 2025 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01AG070913 | Imaging Genetics of Brain Structure and Cognitive Aging in Murine Models of Alzheimer's Disease | 000 | 5 | NIH | 3/4/2025 | $1,048,656 |
| | 2025 | 2025 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01ES033158 | Ionic mechanisms of toluene cerebrovascular actions | 000 | 4 | NIH | 3/4/2025 | $432,183 |
| | 2025 | 2025 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | F31CA290773 | Manipulation of the gut microbiome to delay breast cancer onset and progression in the context of weight loss and obesity | 000 | 1 | NIH | 5/1/2025 | $43,340 |
| | 2025 | 2025 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01AI152067 | Antifungal antagonism as a cause of treatment failure for invasive mycoses | 000 | 5 | NIH | 4/21/2025 | $615,995 |
| | 2025 | 2025 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01AI158442 | Unlocking the cidal activity of echinocandins against Aspergillus fumigatus | 000 | 5 | NIH | 4/21/2025 | $449,016 |
| | 2025 | 2025 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | F31AI191701 | Interrogation of SidB-dependent septation for echinocandin potentiation in invasive aspergillosis treatment | 001 | 1 | NIH | 4/11/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | F31AI191701 | Interrogation of SidB-dependent septation for echinocandin potentiation in invasive aspergillosis treatment | 000 | 1 | NIH | 4/11/2025 | $40,396 |
| | 2025 | 2025 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01AI134796 | Candidalysin: a key mediator of Candida vaginitis immunopathology | 000 | 6 | NIH | 12/17/2024 | $441,284 |
| | 2025 | 2025 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01AG040146 | Rectifying Disparities Associated with Risk Score-Based MTM Eligibility in Enhanced MTM | 000 | 10 | NIH | 3/26/2025 | $276,279 |
| | 2025 | 2025 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01HL019134 | Angiotensins, Prostaglandins and Adrenergic Interactions | 000 | 49 | NIH | 3/28/2025 | $686,841 |
| | 2025 | 2025 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01CA276152 | Targeting brain and bone metastases in metastatic breast cancer for improved patient survival | 000 | 3 | NIH | 4/4/2025 | $553,406 |
| | 2025 | 2025 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R21EY036199 | A generalizable deep learning platform for unifying quantification of experimental autoimmune uveitis | 000 | 1 | NIH | 1/24/2025 | $231,000 |
| | 2025 | 2025 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R33NS124923 | Targeting TRPC3 Channels for Epileptic Seizures | 000 | 3 | NIH | 1/24/2025 | $346,500 |
| | 2025 | 2025 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01ES031656 | Genetics of epigenetic response to high circulating glucocorticoids and organophosphorus compounds | 000 | 5 | NIH | 1/16/2025 | $523,991 |
| | 2025 | 2025 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01HL166411 | Chloride channels in endothelial cells | 000 | 3 | NIH | 2/28/2025 | $564,798 |
| | 2025 | 2025 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01MH135862 | The neuroimmune mechanism of SARS-CoV-2 on synaptic transmission and plasticity | 000 | 1 | NIH | 1/10/2025 | $384,772 |
| | 2025 | 2025 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01DK138872 | Regulation of kidney function and blood pressure in aging | 000 | 2 | NIH | 4/14/2025 | $602,975 |
| | 2025 | 2025 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01HL172809 | RSPO2-LGR4 signaling in atherosclerosis | 000 | 1 | NIH | 1/6/2025 | $559,893 |
| | 2025 | 2025 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01EY030863 | Dynamics of calcium signals control neurotransmitter release in retinal ribbon synapses | 000 | 5 | NIH | 12/20/2024 | $380,000 |
| | 2025 | 2025 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01AI182231 | Development of Microbiome-Sparing Antibacterials for Clostridioides difficile Infection | 000 | 1 | NIH | 12/4/2024 | $754,446 |
| | 2025 | 2025 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01NS140100 | Novel Pharmacological Approach to Stroke Neuroprotection | 000 | 1 | NIH | 12/4/2024 | $459,111 |
| | 2025 | 2025 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01NS120327 | Blood-brain-barrier and white matter mechanisms underlying dementia | 000 | 3 | NIH | 3/11/2025 | $374,931 |
| | 2025 | 2025 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01EY034425 | GRP78 signaling and retinal angiogenesis | 000 | 3 | NIH | 3/14/2025 | $511,066 |
| | 2025 | 2025 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01NS100947 | Inflammatory regulation of epileptogenesis after status epilepticus | 002 | 8 | NIH | 11/22/2024 | $346,500 |
| | 2025 | 2025 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01AI179632 | The molecular mechanism of Siglec-E in bacterial clearance | 000 | 2 | NIH | 4/10/2025 | $462,000 |
| | 2025 | 2025 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | U01DA053672 | Genetics of oxycodone intake in a hybrid rat diversity panel. | 001 | 5 | NIH | 4/8/2025 | $67,192 |
| | 2025 | 2025 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R01MD018174 | Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations | 000 | 3 | NIH | 2/19/2025 | $627,985 |
| | 2025 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | U01CA272541 | Determining the contribution of microbial-derived metabolites to protective immunity in obesity-driven cancer risk. | 000 | 3 | NIH | 4/7/2025 | $0 |
| | 2025 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | NU58DP007592 | The Tennessee Heart Health Network | 01 | 2 | CDC | 5/8/2025 | $0 |
| | 2025 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R35GM150768 | Expanding the small molecule toolbox through novel applications of fluorinated alkenes | 001 | 2 | NIH | 3/25/2025 | $202,631 |
| | 2025 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | R21DA062022 | Neuropeptide S Receptor 1 as a Novel Target for Reducing Opioid Self-Administration and Opioid Relapse | 000 | 1 | NIH | 1/13/2025 | $0 |
| | 2025 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | H79SM085103 | Implementing Multi-system Programs to Strengthen Attachment in Children and Families Affected by Trauma (IMPACT) | 000 | 2 | SAMHSA | 11/4/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF TENNESSEE | 62 S DUNLAP ST | MEMPHIS | TN | 38103-4902 | SHELBY | USA | UC7AI180313 | Enhancement of Resilience of the UTHSC RBL Facility, Biosafety and Countermeasure Discovery | 000 | 2 | NIH | 2/14/2025 | $0 |
|
